#pharmaceuticals

German Regulators Approve Cannabis Extract Exilby for Chronic Pain

Germany has authorized Exilby, a whole-plant cannabis extract, for chronic pain treatment, while the FDA granted it breakthrough therapy sta...

FDA Grants Breakthrough Status to German Cannabis Pain Drug

The FDA granted Breakthrough Therapy Designation to Vertanical's VER-01, a full-spectrum cannabis drug for chronic low back pain, following ...

New Meta-Analysis Links Cannabis Compounds to Anti-Tumor Effects

A new meta-analysis in Pharmaceuticals journal shows cannabis compounds have statistically significant anti-tumor effects in glioblastoma an...